Xiaoguang J. Qiu

No. 119, South 4Th Ring West Road
Fengtai, 100070, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 90 publications

Reply to "Comments on chemoradiotherapy in IDH wild-type/TERT-mutant grade 2/3 gliomas".

Reply to "Comments on chemoradiotherapy in IDH wild-type/TERT-mutant grade 2/3 gliomas".

Journal: Cancer

Published: April 15, 2026

Global Burden and Temporal Trends of Brain and Central Nervous System Tumors in Children and Adolescents: A Systematic Analysis for the Global Burden of Disease Study 2021.

Global Burden and Temporal Trends of Brain and Central Nervous System Tumors in Children and Adolescents: A Systematic Analysis for the Global Burden of Disease Study 2021.

Journal: Cancer innovation

Published: December 30, 2025

The CGCG response assessment criteria for spinal cord gliomas.

The CGCG response assessment criteria for spinal cord gliomas.

Journal: Cancer letters

Published: December 12, 2025

Clinical practice guidelines for the diagnosis and treatment of diffuse glioma-related epilepsy: 2025 update.

Clinical practice guidelines for the diagnosis and treatment of diffuse glioma-related epilepsy: 2025 update.

Journal: Cancer letters

Published: December 04, 2025

Vebreltinib for Previously Treated Astrocytoma, IDH-Mutant, Grade 4, and Glioblastoma, IDH Wild-Type with PTPRZ1-MET Fusion Gene: A Multicenter, Phase III Randomized, Open-Label Trial.

Vebreltinib for Previously Treated Astrocytoma, IDH-Mutant, Grade 4, and Glioblastoma, IDH Wild-Type with PTPRZ1-MET Fusion Gene: A Multicenter, Phase III Randomized, Open-Label Trial.

Journal: Cancer communications (London, England)

Published: November 22, 2025

An integrated cerebrospinal fluid beta-human chorionic gonadotropin and atrophy-targeted magnetic resonance imaging strategy to reduce diagnostic delays in bilateral basal ganglia germinomas: A case series.

An integrated cerebrospinal fluid beta-human chorionic gonadotropin and atrophy-targeted magnetic resonance imaging strategy to reduce diagnostic delays in bilateral basal ganglia germinomas: A case series.

Journal: The Journal of international medical research

Published: November 01, 2025

An ambispective, observational real-world study of tumor-treating fields for treatment of Chinese patients with newly diagnosed or recurrent/progressive glioblastoma.

An ambispective, observational real-world study of tumor-treating fields for treatment of Chinese patients with newly diagnosed or recurrent/progressive glioblastoma.

Journal: Neuro-oncology advances

Published: October 22, 2025

Development and validation of a customised PRO-CTCAE scale for adult-type diffuse gliomas (VERONICA): a multicentre, prospective, observational cohort study in China.

Development and validation of a customised PRO-CTCAE scale for adult-type diffuse gliomas (VERONICA): a multicentre, prospective, observational cohort study in China.

Journal: EClinicalMedicine

Published: September 26, 2025

Updated clinical practice guidelines for the management of adult diffuse gliomas.

Updated clinical practice guidelines for the management of adult diffuse gliomas.

Journal: Cancer letters

Published: September 03, 2025

An interpretable machine learning model for predicting prognosis of medulloblastoma integrating genetic and clinical features.

An interpretable machine learning model for predicting prognosis of medulloblastoma integrating genetic and clinical features.

Journal: Communications medicine

Published: July 14, 2025

Exploring deep learning and hybrid approaches in molecular subgrouping and prognostic-related genetic signatures of medulloblastoma.

Exploring deep learning and hybrid approaches in molecular subgrouping and prognostic-related genetic signatures of medulloblastoma.

Journal: Chinese neurosurgical journal

Published: May 08, 2025

Long-term outcomes by clinical and molecular risk stratification in patients with medulloblastoma receiving risk-adapted therapy.

Long-term outcomes by clinical and molecular risk stratification in patients with medulloblastoma receiving risk-adapted therapy.

Journal: Med (New York, N.Y.)

Published: April 01, 2025

Showing 1-12 of 90

Last Updated: 09/26/2026